News Agency
Men's Weekly

JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with Moderately or Severely Refractory Systemic Lupus Erythematosus

  • Written by PR Newswire

SHANGHAI, April 10, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that it has received the Investigational New Drug (IND) clearance from the National Medical Products Administration (NMPA) of Chin...

Read more: JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with...

How Often Should You Visit the Dentist? Here’s What Experts Say

When it comes to having a healthy smile, perhaps the most frequently asked question is, "How frequently should I go to the dentist?" Although there's a rule of thumb that says visit the dentist every six months, the truth isn't... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion